{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:59:31Z","timestamp":1788022771786,"version":"build-2784847793"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004695","name":"Inyuvesi Yakwazulu-Natali","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024216","name":"College of Health Sciences, University of KwaZulu-Natal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024216","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuroscience.2024.10.031","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:45:19Z","timestamp":1729788319000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Modulation of tenofovir by probenecid: Impact on drug, interleukin-1\u03b2, and dopamine concentration in the prefrontal cortex and cerebellum"],"prefix":"10.1016","volume":"562","author":[{"given":"Simangele NE","family":"Shabalala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Luvuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Mabandla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.10.031_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ics.2005.02.008","article-title":"Physiology of the blood-brain barrier and its consequences for drug transport to the brain","volume":"1277","author":"Abbott","year":"2005","journal-title":"Int. Congr. Ser."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0010","unstructured":"ACID (DOPAC) IN RAT ADRENAL GLAND Akio KAWAGUCHI *, Masami NIWA and Masayori OZAKI ** of Pharmacology of Medicine , Japan Accepted January Abstract-Although norepinephrine and epinephrine are the predominant catecholamines (CAs) in peripheral tissues . 1983;617:611\u20137."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0015","unstructured":"Decreased Homovanilic Acid in Cerebrospinal Fluid Correlates...\u00a0: Clinical Neuropharmacology [Internet]. [cited 2022 Dec 24]. Available from: https:\/\/journals.lww.com\/clinicalneuropharm\/Abstract\/2000\/07000\/Decreased_Homovanilic_Acid_in_Cerebrospinal_Fluid.4.aspx."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.10.031_b0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/135965350601100214","article-title":"Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases","volume":"11","author":"Allavena","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-8454-3-1","article-title":"The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses","volume":"3","author":"Anthonypillai","year":"2006","journal-title":"Cerebrospinal Fluid Res."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0030","first-page":"259","author":"Banks","year":"2006","journal-title":"The Blood-Brain Barrier in NeuroAIDS."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.10.031_b0035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/QAI.0b013e318247ec54","article-title":"Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor","volume":"59","author":"Best","year":"2012","journal-title":"Tenofovir. J Acquir Immune Defic Syndr."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.10.031_b0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.37201\/req\/083.2021","article-title":"Past and future of HIV infection. A document based on expert opinion","volume":"35","author":"Bouza","year":"2022","journal-title":"Rev Espa\u00f1ola Quimioter [internet]."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/B978-0-444-63849-6.00006-2","article-title":"Neurologic sequelae of primary HIV infection","volume":"152","author":"Brew","year":"2018","journal-title":"Handb Clin Neurol [Internet]."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.10.031_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12020171","article-title":"Nanomaterials designed for antiviral drug delivery transport across biological barriers","volume":"12","author":"Cojocaru","year":"2020","journal-title":"Pharmaceutics."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.10.031_b0055","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2174\/18715273113129990090","article-title":"Probenecid: an emerging tool for neuroprotection","volume":"12","author":"Col\u00edn-Gonz\u00e1lez","year":"2013","journal-title":"CNS Neurol Disord - Drug Targets."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.10.031_b0060","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1002\/cpmo.48","article-title":"A method for parasagittal sectioning for neuroanatomical quantification of brain structures in the adult mouse","volume":"8","author":"Collins","year":"2018","journal-title":"Curr. Protoc Mouse Biol."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.10.031_b0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/AAC.42.3.687","article-title":"Pharmacokinetics and bioavailability of the anti-human immunodeficiency virus nucleotide analog 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs","volume":"42","author":"Cundy","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0070","first-page":"1","article-title":"Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid","author":"Decloedt","year":"2021","journal-title":"Southern African J. HIV Medicine"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/rmv.711","article-title":"HIV-1 infection and neurocognitive impairment in the current era","volume":"22","author":"del Palacio","year":"2012","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrn2040","article-title":"HIV and antiretroviral therapy in the brain: neuronal injury and repair","volume":"8","author":"Ellis","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0085","doi-asserted-by":"crossref","unstructured":"Felger, J.C., 2016. The Role of Dopamine in Inflammation- Associated Depression: Mechanisms and Therapeutic Implications.","DOI":"10.1007\/7854_2016_13"},{"issue":"22","key":"10.1016\/j.neuroscience.2024.10.031_b0090","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1007\/s00018-014-1702-4","article-title":"The impact of HIV-1 on neurogenesis: Implications for HAND","volume":"71","author":"Ferrell","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0095","first-page":"1","article-title":"Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice","author":"Fields","year":"2019","journal-title":"Sci. Rep. [Internet]."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0100","first-page":"1","article-title":"Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice","volume":"9","author":"Fields","year":"2019","journal-title":"Sci. Rep. [Internet]."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.10.031_b0105","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/378068","article-title":"Tenofovir disoproxil fumarate","volume":"37","author":"Gallant","year":"2003","journal-title":"Clin. Infect Dis. [Internet]"},{"key":"10.1016\/j.neuroscience.2024.10.031_b0110","first-page":"1","article-title":"Probenecid, an old drug with potential new uses for central nervous system disorders and neuroinflammation","author":"Garc","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11481-009-9168-0","article-title":"Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes","volume":"5","author":"Gelman","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.10.031_b0120","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s11481-012-9345-4","article-title":"Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis","volume":"7","author":"Gelman","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0130","first-page":"988","article-title":"HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment","volume":"14","author":"Gonz\u00e1lez-Scarano","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1007061","article-title":"EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment","volume":"14","author":"Gu","year":"2018","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0125","doi-asserted-by":"crossref","unstructured":"Gomez-zepeda D., Taghi M., Scherrmann J michel, 2019. ABC Transporters at the Blood \u2013 Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas.","DOI":"10.3390\/pharmaceutics12010020"},{"key":"10.1016\/j.neuroscience.2024.10.031_b0145","unstructured":"Mhatre V. Ho, Ji-Ann Lee and KCM, Dien et al. 2013. \u57fa\u56e0\u7684\u6539\u53d8NIH Public Access. Bone [Internet]. 2008;23(1):1\u20137. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3624763\/pdf\/nihms412728.pdf."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0150","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00702-013-1086-x","article-title":"Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10 \/ 10-repeat allele which is more frequent in HIV-infected individuals","author":"Horn","year":"2013","journal-title":"J. Neural Transm."},{"issue":"9","key":"10.1016\/j.neuroscience.2024.10.031_b0160","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1007\/s00018-021-03785-y","article-title":"Mechanisms of neuronal dysfunction in HIV - associated neurocognitive disorders","volume":"78","author":"Irollo","year":"2021","journal-title":"Cell Mol. Life Sci.S [Internet]."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9730467","article-title":"The role of dopamine and its dysfunction as a consequence of oxidative stress","author":"Ju\u00e1rez Olgu\u00edn","year":"2016","journal-title":"Oxid Med. Cell Longev [Internet]."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1258\/ijsa.2009.009451","article-title":"Depression associated with antiretroviral drug therapy in HIV : case report and overview","author":"Kaestner","year":"2012","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.neuroscience.2024.10.031_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2011.00037","article-title":"Drug transport and metabolism in the blood-brain barrier","author":"Kapitulnik","year":"2011","journal-title":"Front Pharmacol [internet]."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0180","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1549549","article-title":"Role of inflammasomes in neuroimmune and neurodegenerative diseases: a systematic review","author":"Lang","year":"2018","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0185","first-page":"70","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol [Internet]"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0190","first-page":"65","volume":"65","author":"Letendre","year":"2009","journal-title":"NIH Public Access."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/psp4.12481","article-title":"Probenecid-boosted tenofovir: a physiologically-based pharmacokinetic model-informed strategy for on-demand HIV preexposure prophylaxis","volume":"9","author":"Liu","year":"2020","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.10.031_b0200","first-page":"1200","volume":"107","author":"Liu","year":"2021","journal-title":"HHS Public Access."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0205","doi-asserted-by":"crossref","unstructured":"Mice M, Lau Y sum, Trobough KL, Crampton JM, Wilson JA. 1990 EFFECTS OF PROBENECID ON STRIATAL DOPAMINE DEPLETION IN ACUTE AND LONG-TERM;21(2):181\u20137.","DOI":"10.1016\/0306-3623(90)90898-V"},{"issue":"5","key":"10.1016\/j.neuroscience.2024.10.031_b0210","first-page":"7","article-title":"Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue","volume":"257","author":"Nagle","year":"2005","journal-title":"Biophys. Chem."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/sajhivmed.v21i1.1115","article-title":"Southern african HIV clinicians society guidelines for antiretroviral therapy in adults: 2020 update","volume":"21","author":"Nel","year":"2020","journal-title":"South Afr. J. HIV Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAD.0000000000000112","article-title":"Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta","volume":"28","author":"Neumanova","year":"2014","journal-title":"AIDS"},{"issue":"25","key":"10.1016\/j.neuroscience.2024.10.031_b0225","doi-asserted-by":"crossref","first-page":"21169","DOI":"10.1021\/acsomega.9b02582","article-title":"Mass spectrometry imaging demonstrates the regional brain distribution patterns of three first-line antiretroviral drugs","volume":"4","author":"Ntshangase","year":"2019","journal-title":"ACS Omega"},{"issue":"21","key":"10.1016\/j.neuroscience.2024.10.031_b0230","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/rcm.8510","article-title":"Spatial distribution of elvitegravir and tenofovir in rat brain tissue: application of matrix-assisted laser desorption\/ionization mass spectrometry imaging and liquid chromatography\/tandem mass spectrometry","volume":"33","author":"Ntshangase","year":"2019","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0235","first-page":"1919","article-title":"Product information product information","volume":"14998","author":"Number","year":"1920","journal-title":"Opadry."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0240","author":"Nwogu","year":"2016","journal-title":"CNS Penetration of Antiretrovirals"},{"issue":"9","key":"10.1016\/j.neuroscience.2024.10.031_b0245","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","article-title":"The paradox of HIV blood-brain barrier penetrance and antiretroviral drug delivery deficiencies","volume":"43","author":"Osborne","year":"2020","journal-title":"Trends Neurosci [Internet]."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0250","unstructured":"HIV Replication Cycle | NIH: National Institute of Allergy and Infectious Diseases [Internet]. [cited 2023 Jan 12]. Available from: https:\/\/www.niaid.nih.gov\/diseases-conditions\/hiv-replication-cycle."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.10.031_b0255","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.42.3.612","article-title":"Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2- phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl)PMPA","volume":"42","author":"Robbins","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.10.031_b0260","first-page":"362","article-title":"Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats","volume":"25","author":"Shaw","year":"1997","journal-title":"Drug Metab. Dispos [Internet]"},{"key":"10.1016\/j.neuroscience.2024.10.031_b0265","doi-asserted-by":"crossref","unstructured":"Silverman W, Locovei S, Dahl G, Silverman W, Locovei S, Dahl G. Probenecid , a gout remedy , inhibits pannexin 1 channels Probenecid , a gout remedy , inhibits pannexin 1 channels. 2013;(July 2008).","DOI":"10.1152\/ajpcell.00227.2008"},{"key":"10.1016\/j.neuroscience.2024.10.031_b0270","doi-asserted-by":"crossref","DOI":"10.1080\/13550280600724319","article-title":"Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1\u2013infected brains","author":"Silvers","year":"2006","journal-title":"J. Neurovirol. [Internet]."},{"issue":"57","key":"10.1016\/j.neuroscience.2024.10.031_b0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-61779-111-6_2","article-title":"Dissection of rodent brain regions","volume":"2011","author":"Spijker","year":"2011","journal-title":"NeuroMethods"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.10.031_b0280","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.02793-15","article-title":"Differential mechanisms of tenofovir and tenofovir disoproxil fumarate cellular transport and implications for topical preexposure prophylaxis","volume":"60","author":"Taneva","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.10.031_b0285","first-page":"1","article-title":"HIV-associated synaptic degeneration","volume":"23","author":"Tierney","year":"2012","journal-title":"Arch. Clin. Neuropsychol [internet]."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.10.031_b0290","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/arclin\/acx083","article-title":"Semantic memory in HIV-associated Neurocognitive disorders: an evaluation of the \u201cCortical\u201d Versus \u201cSubcortical\u201d hypothesis","volume":"33","author":"Tierney","year":"2018","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2014.11.019","article-title":"The organic anion transport inhibitor probenecid increases brain concentrations of the NKCC1 inhibitor bumetanide","volume":"746","author":"T\u00f6llner","year":"2015","journal-title":"Eur. J. Pharmacol. [Internet]."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0300","unstructured":"Treatment-emergent A, Symptoms N. Management of depression associated with HIV \/ AIDS and antiretroviral therapy. 2006;17(December):5\u201310."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.10.031_b0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2008.12.013","article-title":"The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research","volume":"82","author":"Varatharajan","year":"2009","journal-title":"Antiviral Res."},{"issue":"December","key":"10.1016\/j.neuroscience.2024.10.031_b0310","first-page":"1","article-title":"The prevalence of frascati-criteria-based HIV-associated neurocognitive disorder (HAND) in HIV-infected adults: a systematic review and meta-analysis","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0315","unstructured":"WHO. Interim guidelines suppl to the 2016 Consolidated guidelines. WHO Guidel. 2018;(December):82."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0320","first-page":"1","article-title":"Probenecid reduces infection and inflammation in acute Pseudomonas aeruginosa pneumonia","author":"Wonnenberg","year":"2014","journal-title":"Int. J. Med. Microbiol [Internet]."},{"issue":"24","key":"10.1016\/j.neuroscience.2024.10.031_b0325","article-title":"International Immunopharmacology The modulatory role of dopamine receptors in brain neuroin fl ammation","volume":"76","author":"Xia","year":"2019","journal-title":"Int. Immunopharmacol [Internet]."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.10.031_b0330","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jac\/dkr492","article-title":"Antiretroviral drug treatment of CNS HIV-1 infection","volume":"67","author":"Yilmaz","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"October","key":"10.1016\/j.neuroscience.2024.10.031_b0335","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jchemneu.2018.10.003","article-title":"Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi","volume":"94","author":"Zulu","year":"2018","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuroscience.2024.10.031_b0340","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jchemneu.2018.10.003","article-title":"Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi","volume":"94","author":"Zulu","year":"2018","journal-title":"J. Chem. Neuroanat."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.10.031_b0345","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/neu.2020.19","article-title":"Anti-HIV drugs promote b-amyloid deposition and impair learning and memory in BALB\/c mice","volume":"32","author":"Zulu","year":"2020","journal-title":"Acta Neuropsychiatr."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224005438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224005438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T05:03:31Z","timestamp":1731906211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224005438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":68,"alternative-id":["S0306452224005438"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.10.031","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of tenofovir by probenecid: Impact on drug, interleukin-1\u03b2, and dopamine concentration in the prefrontal cortex and cerebellum","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}